CAMBRIDGE, Mass., Sept. 18 /PRNewswire-FirstCall/ -- Vertex
Pharmaceuticals Incorporated (Nasdaq GS: VRTX) will webcast corporate
presentations at Merrill Lynch's Global Pharmaceutical, Biotech and Medtech
Conference on September 21, 2006 and at the UBS Global Life Sciences
Conference on September 26, 2006.
Ian Smith, Executive Vice President and Chief Financial Officer of
Vertex, will present at the Merrill Lynch Conference. The presentation and
discussion will be conducted on Thursday, September 21, 2006 at 10:40 a.m.
BST (5:40 a.m. EDT).
Joshua Boger, Ph.D., President and Chief Executive Officer of Vertex,
will present at the UBS Global Life Sciences Conference on Tuesday,
September 26, 2006 at 1:00 p.m. EDT.
The presentations will be webcast live and may be accessed by visiting
the Vertex website at http://www.vrtx.com. A replay of the webcasts will
also be available on the Company's website for two weeks following the
presentations. To access the webcasts, go to Vertex's website and select
the desired presentation from the 'Events Calendar.' To ensure a timely
connection, it is recommended that users register at least 15 minutes prior
to the scheduled webcast.
About Vertex
Vertex Pharmaceuticals Incorporated is a global biotechnology company
committed to the discovery and development of breakthrough small molecule
drugs for serious diseases. The Company's strategy is to commercialize its
products both independently and in collaboration with major pharmaceutical
companies. Vertex's product pipeline is focused on viral diseases,
inflammation, autoimmune diseases, cancer, pain and bacterial infection.
Vertex co-discovered the HIV protease inhibitor, Lexiva, with
GlaxoSmithKline.
Lexiva is a registered trademark of the GlaxoSmithKline group of
companies.
Vertex's press releases are available at http://www.vrtx.com.
Vertex Contact:
Lora Pike, Manager, Investor Relations, (617) 444-6755
SOURCE Vertex Pharmaceuticals Incorporated
 back to top
Related links:
http://www.vrtx.com/
http://www.prnewswire.com/comp/938395.html/
CONTACT:
Lora Pike, Manager, Investor Relations of
Vertex Pharmaceuticals Incorporated, +1-617-444-6755
|
